Visipaque: A contrast medium option when considering the special needs of your patients.
With more than 30 years of experience providing diagnostic imaging solutions, GE Healthcare offers iodinated contrast media in a choice of osmolality that may help meet the individual needs of your patients.
Every patient case presents a unique clinical scenario. As with any procedure, it is important that the contrast media selection be based on each patient’s medical history, present condition, comorbidities, and reasons for diagnostic assessment.
Visipaque is formulated with balanced electrolytes
Visipaque is enriched with sodium and calcium.1
A range of concentrations and convenient sizes*
- 270 mgI/mL and 320 mgI/mL1
- 50, 100, 150, and 200 mL1
*Concentrations, volumes, and packaging vary from country to country.
Proven to help manage risk in vulnerable patient populations
Interventional patient procedures are becoming more complex and involve increasingly older patients with a greater prevalence of co-morbidities. With the same osmolality as blood Visipaque induces less fluid shift from both red blood cells and endothelial cells than the low-osmolar contrast agents. Visipaque can help reduce kidney injury in high-risk patients.
Visipaque can help deliver diagnostic accuracy by enabling vulnerable contract-enhanced computed tomography (CT) in patients with renal impairment and minimizing contrast-associated pain.
cCTA (Coronary Computed Tomography Angiography)
cCTA is an accurate, cost-effective and patient friendly tool for diagnosing coronary artery disease (CAD) in low-intermediate risk patients. Visipaque is designed for patient comfort and can help improve stent evaluability. it can also help minimize heat sensation and impact on the heart rate.